Autoantibodies as predictors of disease: The clinical and experimental evidence

Autoimmunity Reviews

Volumn 6, Issue 6, 2007, Pages 325-333

  Bizzaro, Nicola ^a  

^a Ospedale Civile   (Italy)

Author keywords

Autoantibodies; Predictive value; Prospective studies

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GLYCINE TRANSFER RNA LIGASE; HISTIDINE TRANSFER RNA LIGASE; LA ANTIBODY; MITOCHONDRION ANTIBODY; MYELIN; PANCREAS ISLET CELL ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; THYROID ANTIBODY;

ADDISON DISEASE; ADRENAL CORTEX; AUTOIMMUNE DISEASE; CELIAC DISEASE; CLINICAL STUDY; CLINICAL TRIAL; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; EXPERIMENTAL STUDY; FALSE POSITIVE RESULT; HUMAN; HYPOTHYROIDISM; IMMUNOASSAY; IMMUNOLOGICAL PARAMETERS; INSULIN DEPENDENT DIABETES MELLITUS; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; POLYMYOSITIS; PREDICTION AND FORECASTING; PREDICTOR VARIABLE; PRIMARY BILIARY CIRRHOSIS; PROSPECTIVE STUDY; REVIEW; RHEUMATOID ARTHRITIS; SACCHAROMYCES CEREVISIAE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS; LONGITUDINAL STUDIES; PROSPECTIVE STUDIES; PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 34249313377     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.01.006     Document Type: Review

References (34)

1. Arbuckle M.R., Mc Clain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349 (2003) 1526-1533
2. McClain M.T., Arbuckle M.R., Heinlen L.D., Dennis G.J., Roebuck J., Rubertone M.V., et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 50 (2004) 1226-1232
3. McCune A.B., Weston W.L., and Lee L.A. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med 106 (1987) 518-523
4. Waltuck J., and Buyon J.P. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 120 (1994) 544-552
5. Iijima T., Tada H., Hidaka Y., Yagoro A., Mitsuda N., Kanzaki T., et al. Prediction of postpartum onset of rheumatoid arthritis. Ann Rheum Dis 57 (1998) 460-463
6. Del Puente A., Knowler W.C., Pettitt D.J., and Bennett P.H. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum 31 (1988) 1239-1244
7. Aho K., Heliovaara M., Maatela J., Tuomi T., and Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 18 (1991) 1282-1284
8. Rantapää-Dahlqvist S., de Jong B.A.W., Berglin E., Hallmans G., Wadell G., Stenlund H., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48 (2003) 2741-2749
9. Nielen M.M., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H.M., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50 (2004) 380-386
10. van Gaalen F.A., Linn-Rasker S., van Venrooij W.J., de Jong B.A., Breedveld F.C., Verweij C.L., et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis. Arthritis Rheum 50 (2004) 709-715
11. Sarkar K., and Miller F.W. Autoantibodies as predictive and diagnostic markers of idiopathic inflammatory myopaties. Autoimmunity 37 (2004) 291-294
12. Betterle C., Zanette F., Zanchetta R., Pedini B., Trevisan A., Mantero T., et al. Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease. Lancet 1 (1983) 1238-1241
13. Betterle C., Volpato M., Rees-Smith B., Furmaniak J., Chen S., Greggio N.A., et al. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases. J Clin Endocrinol Metab 82 (1997) 932-938
14. Betterle C., Volpato M., Rees-Smith B., Furmaniak J., Chen S., Zanchetta R., et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases. J Clin Endocrinol Metab 82 (1997) 939-942
15. Laureti S., De Bellis A., Muccitelli V.I., Calcinaro F., Bizzarro A., Rossi R., et al. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab 83 (1998) 3507-3511
16. Berger T., Rubner P., Schautzer F., Egg R., Ulmer H., Mayringer I., et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 349 (2003) 139-145
17. Turnbridge W.M.G., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., et al. The spectrum of thyroid disease in the community: The Wickham Survey. Clin Endocrinol 7 (1977) 481-493
18. Vanderpump M.P.J., Turnbridge W.M.G., French J.M., Appleton D., Bates D., Clark F., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Wickham Survey. Clin Endocrinol 43 (1995) 55-68
19. Nøhr S.B., Jørgensen A., Pedersen K.M., and Laurberg P. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe?. J Clin Endocrinol Metab 85 (2000) 3191-3198
20. Premawardhana L.D.K.E., Parkes A.B., John R., Harris B., and Lazarus J.H. Thyroid peroxidase antibodies in early pregnancy: utility for prediction of postpartum thyroid dysfunction and implications for screening. Thyroid 14 (2004) 610-615
21. Mitchison H.C., Bassendine M.F., Hendrick A., Bennett M.K., Bird G., Watson A.J., et al. Positive antimitochondrial antibodies but normal alkaline phosphatase: is this primary biliary cirrhosis?. Hepatology 6 (1986) 1279-1284
22. Metcalf J.V., Mitchison H.C., Palmer J.M., Jones D.E., Bassendine M.F., and James O.F.W. Natural history of early primary biliary cirrhosis. Lancet 348 (1996) 1399-1402
23. Prince M.I., Chetwynd A., Craig W.L., Metcalf J.V., and James O.F.W. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 53 (2004) 865-870
24. Bingley P.J., Williams A.J.K., and Gale E.A.M. Optimized autoantibody-based risk assessment in family members. Diabetes Care 22 (1999) 1796-1801
25. Kulmala P., Savola K., Petersen J.S., Vähäsalo P., Karjalainen J., Löppönen T., et al. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. J Clin Invest 101 (1998) 327-336
26. Schlosser M., Strebelow M., Wassmuth R., Arnold M.L., Breunig I., Rjasanowski I., et al. The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of β-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals. J Clin Endocrinol Metab 87 (2002) 2254-2261
27. Kimpimäki T., Kupila A., Hämäläinen A.M., Kukko M., Kulmala P., Savola K., et al. The first signs of β-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish type I diabetes prediction and prevention study. J Clin Endocrinol Metab 86 (2001) 4782-4788
28. Barker J.M., Barriga K.J., Yu L., Miao D., Erlich H.A., Norris J.M., et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 89 (2004) 3896-3902
29. Mäki M., Mustalahti K., Kokkonen J., Kulmala P., Haapalahti M., Karttunen T., et al. Prevalence of celiac disease among children in Finland. N Engl J Med 348 (2003) 2517-2524
30. Hoffenberg E.J., MacKenzie T., Barriga K.J., Eisenbarth G.S., Bao F., Haas J.E., et al. A prospective study of the incidence of childhood celiac disease. J Pediatr 143 (2003) 308-314
31. Simell S., Kupila A., Hoppu S., Hekkala A., Simell T., Ståhlberg M.R., et al. Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand J Gastroenterol 40 (2005) 1182-1191
32. Israeli E., Grotto I., Gilburd B., Balicer R.D., Goldin E., Wiik A., et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54 (2005) 1232-1236
33. Scofield R.H. Autoantibodies as predictors of disease. Lancet 383 (2004) 1544-1546
34. Leslie D., Lipsky P., and Notkins A.L. Autoantibodies as predictors of disease. J Clin Invest 108 (2001) 1417-1422